Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

BAY32-5915

Copy Product Info
😃Good
Catalog No. T20770Cas No. 1571-30-8
Alias BAY-32-5915, BAY 32-5915, BAY 32 5915

BAY32-5915 is a selective inhibitor of IKKalpha.

BAY32-5915

BAY32-5915

Copy Product Info
😃Good
Purity: 97%
Catalog No. T20770Alias BAY-32-5915, BAY 32-5915, BAY 32 5915Cas No. 1571-30-8
BAY32-5915 is a selective inhibitor of IKKalpha.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
100 mg$39In StockIn Stock
500 mg$84-In Stock
1 mL x 10 mM (in DMSO)$29In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

BAY32-5915 AI Summary
BAY32-5915 is a broad-spectrum inhibitor exhibiting bioactivities across various biological assays. It significantly inhibits human JMJD2E, MLL CXXC domain-DNA interaction, Giardia lamblia fructose-1,6-bisphosphate aldolase, Bacillus subtilis Sfp phosphopantetheinyl transferase, and BAZ2B, with potencies ranging from 366.3 nM to 350,000 nM. The compound shows diverse inhibitory effects on several human recombinant matrix metalloproteinases (MMPs), lipoxygenase, and mushroom tyrosinase, as well as notable inhibition of anthrax lethal factor and bacterial metallo-beta-lactamases (NDM-1, VIM-1, IMP-1). Additionally, it induces DNA re-replication in SW480 colon adenocarcinoma cells and activates integrin pathways beneficial for muscular dystrophy. BAY32-5915 has a LogD7.4 value of 3.3, suggesting favorable distribution in biological systems. It also inhibits Mycobacterium tuberculosis fructose-1,6-bisphosphate aldolase with an IC50 of 10,000 nM and exerts potent inhibition against bacterial enzymes, showing potential as an antibiotic and antiparasitic candidate. The compound exhibits inhibition of Clostridium botulinum BoNT/A1 and recombinant human quinolinic acid carboxylase enzyme, further illustrating its diverse inhibitory profile..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
BAY32-5915 is a selective inhibitor of IKKalpha.
Targets&IC50
IKKα:60 nM
SynonymsBAY-32-5915, BAY 32-5915, BAY 32 5915
Chemical Properties
Molecular Weight189.17
FormulaC10H7NO3
Cas No.1571-30-8
SmilesOC(=O)C1=NC2=C(O)C=CC=C2C=C1
Relative Density.1.3175 g/cm3 (Estimated)
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 55 mg/mL (290.74 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM5.2863 mL26.4313 mL52.8625 mL264.3125 mL
5 mM1.0573 mL5.2863 mL10.5725 mL52.8625 mL
10 mM0.5286 mL2.6431 mL5.2863 mL26.4313 mL
20 mM0.2643 mL1.3216 mL2.6431 mL13.2156 mL
50 mM0.1057 mL0.5286 mL1.0573 mL5.2863 mL
100 mM0.0529 mL0.2643 mL0.5286 mL2.6431 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BAY32-5915 | purchase BAY32-5915 | BAY32-5915 cost | order BAY32-5915 | BAY32-5915 chemical structure | BAY32-5915 formula | BAY32-5915 molecular weight